MME and hydrops fetalis: Another significant difference is that our study was performed after the incorporation of angiotensin receptor–neprilysin inhibitors (ARNIs) in the guideline-directed medical therapy for HF with a reduced ejection fraction [10], and, thus, a number of patients were already receiving ARNIs.